From traditional vaccines to an era of novel approaches to preventive and therapeutic vaccine-like products, coupled with new adjuvants and delivery systems, knowing the right approach to demonstrate nonclinical proof-of-concept and safety is essential. Our team of expert immunologists, toxicologists, and program managers will help you develop a tailored nonclinical program for your vaccine candidate.
Because our team has been in the industry for so long, we understand that vaccine development programs have many challenges. The following roadblocks are frequently encountered during the development:
I have had the pleasure of working with KreaMedica on several programs. They proactively identified and addressed issues and provided regular updates to ensure everyone was on the same page. Their attention to detail and willingness to take ownership of the project’s success makes them invaluable partners. They are great to work with, and I would highly recommend them to anyone looking for a drug development partner.
They supplemented and filled in gaps in our internal network and worked well with our advisors. They truly wanted to contribute to and be part of the project’s success. I highly recommend Claude, Poulomee, and Rudi as reliable partners for planning and executing toxicological and bioanalytical projects.
I have worked with KreaMedica for many years, and I must credit them for the team’s talent, professionalism, and chemistry. That doesn’t happen by accident. As a consultant, I rely on them as the first line to monitor studies and provide proactive solutions when required.